𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High dose intravenous methylprednisolone “pulse” therapy in patients with rheumatoid disease

✍ Scribed by E. M. Baylis; I. A. Williams; J. English; V. Marks; J. Chakraborty

Publisher
Springer
Year
1982
Tongue
English
Weight
486 KB
Volume
21
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic interstitial lung disease in chi
Chronic interstitial lung disease in children: Response to high-dose intravenous methylprednisolone pulses
✍ Pascale Desmarquest; Aline Tamalet; Brigitte Fauroux; Michele Boule; Liliane Boc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

The prognosis for children with chronic interstitial lung disease is poor and the mortality rate is high, especially in infants. This explains the many therapeutical protocols which have been proposed and investigated by several authors. In the present work, we evaluated the response of three infant

Systemic bioavailability and pharmacokin
Systemic bioavailability and pharmacokinetics of methylprednisolone in patients with rheumatoid arthritis following ‘high-dose’ pulse administration
✍ P. K. Narang; R. Wilder; D. C. Chatterji; R. L. Yeager; J. F. Gallelli 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

The absolute and relative bioavailability of two methylprednisolone formulations (capsules and suspension) was determined along with its pharmacokinetics in -four arthritic female patients, following an unconventional high-dose pulse of 1 g. Plasma concentrations of the drug were measured by a sensi

High dose oral methylprednisolone in pat
High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical response
✍ P. J. Hayball; D. G. Cosh; M. J. Ahern; D. W. Schultz; P. J. Roberts-Thomson 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 436 KB

A commercially available 1.0 g intravenous (i.v.) dosage formulation of methylprednisolone, as the sodium hemisuccinate salt (Solu Medrol, Upjohn) was administered both parenterally and orally (pulse steroid therapy) on separate occasions, to eight elderly (mean 65 y) patients with active rheumatoid